294 related articles for article (PubMed ID: 21504576)
61. Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells.
Loré K; Smed-Sörensen A; Vasudevan J; Mascola JR; Koup RA
J Exp Med; 2005 Jun; 201(12):2023-33. PubMed ID: 15967828
[TBL] [Abstract][Full Text] [Related]
62. The interaction of immunodeficiency viruses with dendritic cells.
Steinman RM; Granelli-Piperno A; Pope M; Trumpfheller C; Ignatius R; Arrode G; Racz P; Tenner-Racz K
Curr Top Microbiol Immunol; 2003; 276():1-30. PubMed ID: 12797441
[TBL] [Abstract][Full Text] [Related]
63. Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains.
Bego MG; Cong L; Mack K; Kirchhoff F; Cohen ÉA
J Virol; 2016 Nov; 90(22):10236-10246. PubMed ID: 27581991
[TBL] [Abstract][Full Text] [Related]
64. Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.
Arenaccio C; Chiozzini C; Columba-Cabezas S; Manfredi F; Affabris E; Baur A; Federico M
J Virol; 2014 Oct; 88(19):11529-39. PubMed ID: 25056899
[TBL] [Abstract][Full Text] [Related]
65. Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction.
Ilinskaya A; Derse D; Hill S; Princler G; Heidecker G
Virology; 2013 Feb; 436(1):201-9. PubMed ID: 23260108
[TBL] [Abstract][Full Text] [Related]
66. Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells.
Coleman CM; Gelais CS; Wu L
Adv Exp Med Biol; 2013; 762():109-30. PubMed ID: 22975873
[TBL] [Abstract][Full Text] [Related]
67. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells.
Granelli-Piperno A; Finkel V; Delgado E; Steinman RM
Curr Biol; 1999 Jan; 9(1):21-9. PubMed ID: 9889121
[TBL] [Abstract][Full Text] [Related]
68. Synthetic Abortive HIV-1 RNAs Induce Potent Antiviral Immunity.
Stunnenberg M; Sprokholt JK; van Hamme JL; Kaptein TM; Zijlstra-Willems EM; Gringhuis SI; Geijtenbeek TBH
Front Immunol; 2020; 11():8. PubMed ID: 32038656
[TBL] [Abstract][Full Text] [Related]
69. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.
Pillai SK; Abdel-Mohsen M; Guatelli J; Skasko M; Monto A; Fujimoto K; Yukl S; Greene WC; Kovari H; Rauch A; Fellay J; Battegay M; Hirschel B; Witteck A; Bernasconi E; Ledergerber B; Günthard HF; Wong JK;
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3035-40. PubMed ID: 22315404
[TBL] [Abstract][Full Text] [Related]
70. Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes.
Su B; Xu K; Lederle A; Peressin M; Biedma ME; Laumond G; Schmidt S; Decoville T; Proust A; Lambotin M; Holl V; Moog C
Blood; 2012 Nov; 120(18):3708-17. PubMed ID: 22955927
[TBL] [Abstract][Full Text] [Related]
71. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
[TBL] [Abstract][Full Text] [Related]
72. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
Yu J; Liang C; Liu SL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
[TBL] [Abstract][Full Text] [Related]
73. Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.
Engelmayer J; Larsson M; Lee A; Lee M; Cox WI; Steinman RM; Bhardwaj N
J Virol; 2001 Mar; 75(5):2142-53. PubMed ID: 11160718
[TBL] [Abstract][Full Text] [Related]
74. Human immunodeficiency virus type 1 Nef mediates activation of STAT3 in immature dendritic cells.
Messmer D; Bromberg J; Devgan G; Jacqué JM; Granelli-Piperno A; Pope M
AIDS Res Hum Retroviruses; 2002 Sep; 18(14):1043-50. PubMed ID: 12396456
[TBL] [Abstract][Full Text] [Related]
75. Dectin-1/TLR2 and NOD2 agonists render dendritic cells susceptible to infection by X4-using HIV-1 and promote cis-infection of CD4(+) T cells.
Côté SC; Plante A; Tardif MR; Tremblay MJ
PLoS One; 2013; 8(7):e67735. PubMed ID: 23844079
[TBL] [Abstract][Full Text] [Related]
76. Cholecalciferol modulates the phenotype of differentiated monocyte-derived dendritic cells without altering HIV-1 transfer to CD4+ T cells.
Gonzalez SM; Aguilar-Jimenez W; Alvarez N; Rugeles MT
Horm Mol Biol Clin Investig; 2019 Sep; 40(1):. PubMed ID: 31539353
[TBL] [Abstract][Full Text] [Related]
77. HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes.
Lichtner M; Marañón C; Vidalain PO; Azocar O; Hanau D; Lebon P; Burgard M; Rouzioux C; Vullo V; Yagita H; Rabourdin-Combe C; Servet C; Hosmalin A
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):175-82. PubMed ID: 15018705
[TBL] [Abstract][Full Text] [Related]
78. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
[TBL] [Abstract][Full Text] [Related]
79. Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation.
El-Far M; Ancuta P; Routy JP; Zhang Y; Bakeman W; Bordi R; DaFonseca S; Said EA; Gosselin A; Tep TS; Eichbaum Q; van Grevenynghe J; Schwartz O; Freeman GJ; Haddad EK; Chomont N; Sékaly RP
J Gen Virol; 2015 Jun; 96(Pt 6):1463-1477. PubMed ID: 25626682
[TBL] [Abstract][Full Text] [Related]
80. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
Tokarev A; Skasko M; Fitzpatrick K; Guatelli J
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1197-210. PubMed ID: 19929170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
